(1)
Degli Esposti, L.; Perrone, V.; Sangiorgi, D.; Sinigaglia, L. Assessment of Patients Affected by Rheumatoid Arthritis Eligible for Biotechnological Agents and Evaluation of Their Healthcare Resource Utilization and Related Costs. Reumatismo 2021, 73, 5-14.